AMGEN INC (1AMGN.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1AMGN - US0311621009 - Common Stock
278.45 EUR
-16.45 (-5.58%)
Overall 1AMGN gets a fundamental rating of 5 out of 10. We evaluated 1AMGN against 83 industry peers in the Biotechnology industry. 1AMGN scores excellent on profitability, but there are concerns on its financial health. 1AMGN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
1AMGN had positive earnings in the past year.
In the past year 1AMGN had a positive cash flow from operations.
1AMGN had positive earnings in each of the past 5 years.
Each year in the past 5 years 1AMGN had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 7.77%, 1AMGN belongs to the top of the industry, outperforming 81.93% of the companies in the same industry.
1AMGN has a better Return On Equity (72.82%) than 97.59% of its industry peers.
Looking at the Return On Invested Capital, with a value of 15.39%, 1AMGN belongs to the top of the industry, outperforming 89.16% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for 1AMGN is in line with the industry average of 12.51%.
The 3 year average ROIC (13.04%) for 1AMGN is below the current ROIC(15.39%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.77% | ||
| ROE | 72.82% | ||
| ROIC | 15.39% |
ROA(3y)7.14%
ROA(5y)8.52%
ROE(3y)118.78%
ROE(5y)104.3%
ROIC(3y)13.04%
ROIC(5y)14.18%
1.3 Margins
With an excellent Profit Margin value of 19.47%, 1AMGN belongs to the best of the industry, outperforming 83.13% of the companies in the same industry.
In the last couple of years the Profit Margin of 1AMGN has declined.
1AMGN has a Operating Margin of 33.57%. This is amongst the best in the industry. 1AMGN outperforms 87.95% of its industry peers.
In the last couple of years the Operating Margin of 1AMGN has declined.
Looking at the Gross Margin, with a value of 72.06%, 1AMGN is in the better half of the industry, outperforming 61.45% of the companies in the same industry.
1AMGN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.57% | ||
| PM (TTM) | 19.47% | ||
| GM | 72.06% |
OM growth 3Y-6.36%
OM growth 5Y-7.03%
PM growth 3Y-18.6%
PM growth 5Y-18.28%
GM growth 3Y-2.94%
GM growth 5Y-3.32%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1AMGN is creating value.
1AMGN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, 1AMGN has less shares outstanding
Compared to 1 year ago, 1AMGN has an improved debt to assets ratio.
2.2 Solvency
1AMGN has a debt to FCF ratio of 4.28. This is a neutral value as 1AMGN would need 4.28 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.28, 1AMGN is in the better half of the industry, outperforming 75.90% of the companies in the same industry.
1AMGN has a Debt/Equity ratio of 5.45. This is a high value indicating a heavy dependency on external financing.
1AMGN has a worse Debt to Equity ratio (5.45) than 67.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.45 | ||
| Debt/FCF | 4.28 | ||
| Altman-Z | N/A |
ROIC/WACC1.81
WACC8.51%
2.3 Liquidity
A Current Ratio of 1.28 indicates that 1AMGN should not have too much problems paying its short term obligations.
With a Current ratio value of 1.28, 1AMGN is not doing good in the industry: 67.47% of the companies in the same industry are doing better.
A Quick Ratio of 0.99 indicates that 1AMGN may have some problems paying its short term obligations.
The Quick ratio of 1AMGN (0.99) is worse than 68.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.28 | ||
| Quick Ratio | 0.99 |
3. Growth
3.1 Past
1AMGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.79%, which is quite good.
Measured over the past 5 years, 1AMGN shows a small growth in Earnings Per Share. The EPS has been growing by 5.97% on average per year.
Looking at the last year, 1AMGN shows a quite strong growth in Revenue. The Revenue has grown by 10.56% in the last year.
The Revenue has been growing slightly by 7.43% on average over the past years.
EPS 1Y (TTM)13.79%
EPS 3Y5.02%
EPS 5Y5.97%
EPS Q2Q%1.08%
Revenue 1Y (TTM)10.56%
Revenue growth 3Y8.76%
Revenue growth 5Y7.43%
Sales Q2Q%12.4%
3.2 Future
The Earnings Per Share is expected to grow by 4.18% on average over the next years.
Based on estimates for the next years, 1AMGN will show a small growth in Revenue. The Revenue will grow by 3.22% on average per year.
EPS Next Y8.22%
EPS Next 2Y5.36%
EPS Next 3Y4.87%
EPS Next 5Y4.18%
Revenue Next Year7.43%
Revenue Next 2Y4.6%
Revenue Next 3Y3.97%
Revenue Next 5Y3.22%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
1AMGN is valuated correctly with a Price/Earnings ratio of 14.84.
Based on the Price/Earnings ratio, 1AMGN is valued cheaper than 85.54% of the companies in the same industry.
When comparing the Price/Earnings ratio of 1AMGN to the average of the S&P500 Index (26.34), we can say 1AMGN is valued slightly cheaper.
With a Price/Forward Earnings ratio of 14.75, 1AMGN is valued correctly.
Based on the Price/Forward Earnings ratio, 1AMGN is valued cheaper than 91.57% of the companies in the same industry.
1AMGN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.56, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.84 | ||
| Fwd PE | 14.75 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1AMGN is valued a bit cheaper than the industry average as 79.52% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, 1AMGN is valued cheaper than 89.16% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.7 | ||
| EV/EBITDA | 12.44 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of 1AMGN may justify a higher PE ratio.
PEG (NY)1.8
PEG (5Y)2.49
EPS Next 2Y5.36%
EPS Next 3Y4.87%
5. Dividend
5.1 Amount
1AMGN has a Yearly Dividend Yield of 2.83%.
1AMGN's Dividend Yield is rather good when compared to the industry average which is at 8.14. 1AMGN pays more dividend than 95.18% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.31, 1AMGN pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.83% |
5.2 History
On average, the dividend of 1AMGN grows each year by 9.41%, which is quite nice.
Dividend Growth(5Y)9.41%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
17.20% of the earnings are spent on dividend by 1AMGN. This is a low number and sustainable payout ratio.
1AMGN's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP17.2%
EPS Next 2Y5.36%
EPS Next 3Y4.87%
BIT:1AMGN (12/8/2025, 7:00:00 PM)
278.45
-16.45 (-5.58%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners84.15%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap149.91B
Revenue(TTM)35.97B
Net Income(TTM)7.00B
Analysts72
Price Target281.35 (1.04%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.83% |
Yearly Dividend7.82
Dividend Growth(5Y)9.41%
DP17.2%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.96%
Min EPS beat(2)10.28%
Max EPS beat(2)11.64%
EPS beat(4)4
Avg EPS beat(4)9.04%
Min EPS beat(4)2.49%
Max EPS beat(4)11.73%
EPS beat(8)7
Avg EPS beat(8)5.13%
EPS beat(12)10
Avg EPS beat(12)4.44%
EPS beat(16)14
Avg EPS beat(16)4.21%
Revenue beat(2)2
Avg Revenue beat(2)2.59%
Min Revenue beat(2)0.68%
Max Revenue beat(2)4.49%
Revenue beat(4)3
Avg Revenue beat(4)1.17%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)4.49%
Revenue beat(8)3
Avg Revenue beat(8)-0.21%
Revenue beat(12)4
Avg Revenue beat(12)-0.48%
Revenue beat(16)5
Avg Revenue beat(16)-0.54%
PT rev (1m)2.56%
PT rev (3m)0.42%
EPS NQ rev (1m)-7.77%
EPS NQ rev (3m)-11.23%
EPS NY rev (1m)-0.21%
EPS NY rev (3m)0.99%
Revenue NQ rev (1m)1.1%
Revenue NQ rev (3m)1.98%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)1.02%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.84 | ||
| Fwd PE | 14.75 | ||
| P/S | 4.86 | ||
| P/FCF | 13.7 | ||
| P/OCF | 13.31 | ||
| P/B | 18.16 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.44 |
EPS(TTM)18.76
EY6.74%
EPS(NY)18.88
Fwd EY6.78%
FCF(TTM)20.33
FCFY7.3%
OCF(TTM)20.92
OCFY7.51%
SpS57.33
BVpS15.33
TBVpS-51.31
PEG (NY)1.8
PEG (5Y)2.49
Graham Number80.44
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.77% | ||
| ROE | 72.82% | ||
| ROCE | 17.67% | ||
| ROIC | 15.39% | ||
| ROICexc | 17.86% | ||
| ROICexgc | 61.56% | ||
| OM | 33.57% | ||
| PM (TTM) | 19.47% | ||
| GM | 72.06% | ||
| FCFM | 35.46% |
ROA(3y)7.14%
ROA(5y)8.52%
ROE(3y)118.78%
ROE(5y)104.3%
ROIC(3y)13.04%
ROIC(5y)14.18%
ROICexc(3y)15.77%
ROICexc(5y)17.27%
ROICexgc(3y)75.76%
ROICexgc(5y)77.1%
ROCE(3y)14.97%
ROCE(5y)16.28%
ROICexgc growth 3Y3.26%
ROICexgc growth 5Y-18.2%
ROICexc growth 3Y-8.67%
ROICexc growth 5Y-7.85%
OM growth 3Y-6.36%
OM growth 5Y-7.03%
PM growth 3Y-18.6%
PM growth 5Y-18.28%
GM growth 3Y-2.94%
GM growth 5Y-3.32%
F-Score7
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.45 | ||
| Debt/FCF | 4.28 | ||
| Debt/EBITDA | 2.97 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.3% | ||
| Profit Quality | 182.08% | ||
| Current Ratio | 1.28 | ||
| Quick Ratio | 0.99 | ||
| Altman-Z | N/A |
F-Score7
WACC8.51%
ROIC/WACC1.81
Cap/Depr(3y)24.77%
Cap/Depr(5y)23.42%
Cap/Sales(3y)3.59%
Cap/Sales(5y)3.31%
Profit Quality(3y)165.92%
Profit Quality(5y)155.23%
High Growth Momentum
Growth
EPS 1Y (TTM)13.79%
EPS 3Y5.02%
EPS 5Y5.97%
EPS Q2Q%1.08%
EPS Next Y8.22%
EPS Next 2Y5.36%
EPS Next 3Y4.87%
EPS Next 5Y4.18%
Revenue 1Y (TTM)10.56%
Revenue growth 3Y8.76%
Revenue growth 5Y7.43%
Sales Q2Q%12.4%
Revenue Next Year7.43%
Revenue Next 2Y4.6%
Revenue Next 3Y3.97%
Revenue Next 5Y3.22%
EBIT growth 1Y93.73%
EBIT growth 3Y1.84%
EBIT growth 5Y-0.13%
EBIT Next Year39.98%
EBIT Next 3Y10.33%
EBIT Next 5Y7.12%
FCF growth 1Y36%
FCF growth 3Y7.44%
FCF growth 5Y4.03%
OCF growth 1Y24.04%
OCF growth 3Y7.45%
OCF growth 5Y4.66%
AMGEN INC / 1AMGN.MI FAQ
Can you provide the ChartMill fundamental rating for AMGEN INC?
ChartMill assigns a fundamental rating of 5 / 10 to 1AMGN.MI.
Can you provide the valuation status for AMGEN INC?
ChartMill assigns a valuation rating of 6 / 10 to AMGEN INC (1AMGN.MI). This can be considered as Fairly Valued.
How profitable is AMGEN INC (1AMGN.MI) stock?
AMGEN INC (1AMGN.MI) has a profitability rating of 7 / 10.
What is the valuation of AMGEN INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for AMGEN INC (1AMGN.MI) is 14.84 and the Price/Book (PB) ratio is 18.16.
What is the financial health of AMGEN INC (1AMGN.MI) stock?
The financial health rating of AMGEN INC (1AMGN.MI) is 3 / 10.